Pearl Therapeutics to Present Complete PT003 Results from Phase 2b COPD Study … – PipelineReview.com (press release)
Pearl Therapeutics to Present Complete PT003 Results from Phase 2b COPD Study ... PipelineReview.com (press release) Pearl Therapeutics Inc. announced today that complete results from the Company's Phase 2b study of PT003 in patients with moderate-to-very severe COPD will be presented during a late-breaker poster session at the upcoming annual meeting of the American ... Pearl Therapeutics to Present Complete PT003 Results from Phase 2b COPD Study ...Bradenton Herald all 4 news articles » |

